James E. Wagner Cultivation Corporation (JWCAF)
James E. Wagner Cultivation Corporation, operating primarily through its subsidiary, James E. Wagner Cultivation Ltd., is a Canadian enterprise focused on the growth and supply of cannabis for medical purposes. The company distinguishes itself by committing to the production of pure and uniform cannabis products, leveraging its exclusive aeroponic cultivation technology, dubbed GrowthSTORM. This firm was established in 2007 and has its main operational base in Kitchener, Canada.
Sector: Drug Manufacturers - Specialty & Generic
Industry: Drug Manufacturers - Specialty & Generic
James E. Wagner Cultivation Corporation
OTC:JWCAFHealthcare · Drug Manufacturers - Specialty & Generic
CLOSED
Mkt Cap-
EV-
Float101.73M
O/S109.42M
VOL3K sh
Inst Own-
Net Cash/Sh-$0.03
Dilution
MCap-Float101.73MO/S109.42M
Dilution
Financials Summary
Revenue$1.49M
Net Income-$4.89M
Total Assets$15.32M
Free Cash Flow-$12.62M
Debt & Equity
Debt 31%
Equity 69%
Total Debt$3.67M
Total Equity$7.99M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
- 1:4.8Reverse splitJun 11, 20184.8 shares → 1
Balance Sheet Details
Assets$15.32M
Liabilities$7.33M
Accounts Receivable$829K
Accounts Payable$1.49M
Inventory$3.19M
PP&E (Net)$10.02M
Goodwill$0
Intangible Assets$59K
Income Statement
| Period | FY 2019 | FY 2018 |
|---|---|---|
| Currency | USD | USD |
| Period Ending | 2019-09-30 | 2018-09-30 |
| Revenue | $1.49M | $40K |
| YoY Growth | 3598.6% | - |
| Cost of Revenue | $2.82M | -$562K |
| Gross Profit | -$1.33M | $602K |
| Gross Margin | -89.2% | 1493.6% |
| Research and Development | $0 | $0 |
| Selling, General, and Administrative | $5.13M | $5.48M |
| Other | $0 | $0 |
| Total Operating Expenses | $5.13M | $5.65M |
| Operating Income (EBIT) | -$6.46M | -$6.3M |
| Operating Margin | -433.1% | -15631.5% |
| Interest Expense | $339K | $208K |
| Interest Income | $61K | $122K |
| Other Income (Expense) | $1.57M | -$916K |
| Income Before Tax (EBT) | -$4.89M | -$7.22M |
| Income Tax Expense | $0 | $0 |
| Net Income | -$4.89M | -$7.22M |
| Net Income Margin | -327.9% | -17902.4% |
| Supplementary Data | ||
| EPS | -0.08 | -0.14 |
| Diluted EPS | -0.07 | -0.14 |
| Weighted Average OS | 92.52M | 73.67M |
| EBITDA | -$5.1M | -$4.79M |
| EBITDA Margin | -341.8% | -11884.5% |
Balance Sheet
| Period | FY 2019 | FY 2018 |
|---|---|---|
| Currency | USD | USD |
| Period Ending | 2019-09-30 | 2018-09-30 |
| Assets | ||
| Current Assets | ||
| Cash and Cash Equivalents | $723K | $5.95M |
| Short-Term Investments | $0 | $4.21M |
| Cash and Short-Term Investments | $723K | $10.17M |
| Accounts Receivable | $829K | $325K |
| Inventory | $3.19M | $1.07M |
| Other Current Assets | $501K | $851K |
| Total Current Assets | $5.24M | $13.07M |
| Long-Term Assets | ||
| Property, Plant & Equipment Net | $10.02M | $3.73M |
| Goodwill | $0 | $0 |
| Intangible Assets | $59K | $325K |
| Long-Term Investments | $0 | $0 |
| Deferred Tax Assets | $0 | $0 |
| Other Long-Term Assets | $0 | $0 |
| Total Long-Term Assets | $10.08M | $3.83M |
| Other Assets | $0 | $0 |
| Total Assets | $15.32M | $16.91M |
| Liabilities | ||
| Current Liabilities | ||
| Accounts Payable | $1.49M | $0 |
| Short-Term Debt | $2.04M | $2K |
| Current Income Tax Payable | $0 | $0 |
| Current Unearned Revenue | $0 | $0 |
| Other Current Liabilities | $0 | $769K |
| Total Current Liabilities | $3.53M | $771K |
| Long-Term Liabilities | ||
| Long-Term Debt | $2.15M | $4K |
| Long-Term Unearned Revenue | $846K | $2.38M |
| Long-Term Deferred Tax Liabilities | $0 | $0 |
| Other Long-Term Liabilities | $794K | $0 |
| Total Long-Term Liabilities | $3.79M | $2.39M |
| Other Liabilities | $0 | $0 |
| Total Liabilities | $7.33M | $3.16M |
| Stockholders' Equity | ||
| Preferred Stock | $0 | $0 |
| Common Stock | $19.49M | $21.31M |
| Retained Earnings | -$12.83M | -$10.51M |
| Comprehensive Income & Other | $20.82M | $0 |
| Other Stockholders' Equity | $1.33M | $2.94M |
| Total Equity | $7.99M | $13.75M |
| Minority Interest | $0 | $0 |
| Total Liabilities and Equity | $15.32M | $16.91M |
| Supplementary Data | ||
| Total Debt | $3.67M | $6K |
| Net Debt | $2.94M | -$5.95M |
Cash Flow Statement
| Period | FY 2019 | FY 2018 |
|---|---|---|
| Currency | USD | USD |
| Period Ending | 2019-09-30 | 2018-09-30 |
| Operating Activities | ||
| Net Income | -$4.89M | -$7.22M |
| Depreciation & Amortization | $929K | $254K |
| Deferred Income Tax | $1.29M | $0 |
| Stock-Based Compensation | $112K | $736K |
| Changes in Working Capital: | ||
| Accounts Receivable | -$583K | -$84K |
| Inventory | -$882K | -$1.05M |
| Accounts Payable | $911K | $0 |
| Other Working Capital | $1.16M | -$98K |
| Total Working Capital Change | $606K | -$575K |
| Other Non-Cash Items | -$3.05M | $2.73M |
| Net Cash from Operating | -$5.01M | -$4.07M |
| Investing Activities | ||
| Capital Expenditures | -$7.62M | -$3.44M |
| Acquisitions | $0 | $0 |
| Purchases of Investments | $0 | -$4.23M |
| Sales of Investments | $3.18M | $0 |
| Other Investing Activities | $0 | $0 |
| Net Cash from Investing | -$4.43M | -$7.65M |
| Financing Activities | ||
| Debt Repaid | -$4.61M | $263K |
| Common Stock Issuance | $2.99M | $14.03M |
| Common Stock Repurchases | $0 | $0 |
| Dividends Paid | $0 | $0 |
| Other Financing Activities | $5.59M | -$897K |
| Net Cash from Financing | $5.59M | $12.87M |
| Forex Effect | -$1.22M | $0 |
| Net Change in Cash | -$5.07M | $1.15M |
| Supplementary Data | ||
| Operating Cash Flow | -$5.01M | -$4.07M |
| Capital Expenditure | -$7.62M | -$3.44M |
| Free Cash Flow | -$12.62M | -$7.51M |
| Cash at Beginning | $5.95M | $4.8M |
| Cash at End | $887K | $5.95M |